Global Oncology Academy
Popular
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
- NEW EPISODEMinuteCE®
ADT Intensification in Biochemically Recurrent Prostate Cancer: When to Act
1.00 program creditScott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Alexandria May, PharmD, BCPS
Prithviraj Bose, MD
Javier Cortes, MD, PhD
Tiffany Traina, MD, FASCO
Javier Cortes, MD, PhD
Tiffany Traina, MD, FASCO
Javier Cortes, MD, PhD
Charles Turck, PharmD, BCPS, BCCCP
Bilal Siddiqui, MD
Medical News
- 07/20/2026
- 07/20/2026
- Medical NewsARCHER Trial Explores Vaccine Strategy to Prevent ALK Inhibitor Resistance in Advanced NSCLC07/17/2026
- 07/14/2026
CME/CE
- MinuteCE®
Managing Adverse Events Associated With TROP2-Directed ADCs in Metastatic TNBC
0.75 program creditsTiffany Traina, MD, FASCO
Tiffany Traina, MD, FASCO
Clinical Practice
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Javier Cortes, MD, PhD
Tiffany Traina, MD, FASCO
Javier Cortes, MD, PhD
- CME/CE
Precision Through the Continuum: Applying Biomarker-Guided Therapies in Ovarian Cancer
1.00 creditSusana Campos, MD, MPH
Robert Coleman, MD, FACOG
Debra Richardson, MD
Programs
- NEW EPISODEMinuteCE®
Cracking the Code: Risk Stratification Guidelines to Identify High-Risk Patients
1.00 program creditScott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Steve Jackson, PharmD
Jahan Aghalar, MD
Ulka Vaishampayan, MD
- CME/CE In-Person & Virtual Event
Today’s CLL/SLL Decisions, Tomorrow’s Options: Practical Strategies for the Community Clinic
September 11, 2026
Houston, Texas Neeraj Agarwal, MD, FASCO
Rana McKay, MD